FR3010904B1 - Bacteries du genre stenotrophomonas et/ou inducteur de croissance desdites bacteries pour la prevention et/ou le traitement de la dermatite atopique - Google Patents
Bacteries du genre stenotrophomonas et/ou inducteur de croissance desdites bacteries pour la prevention et/ou le traitement de la dermatite atopiqueInfo
- Publication number
- FR3010904B1 FR3010904B1 FR1359246A FR1359246A FR3010904B1 FR 3010904 B1 FR3010904 B1 FR 3010904B1 FR 1359246 A FR1359246 A FR 1359246A FR 1359246 A FR1359246 A FR 1359246A FR 3010904 B1 FR3010904 B1 FR 3010904B1
- Authority
- FR
- France
- Prior art keywords
- bacteria
- prevention
- treatment
- atopic dermatitis
- growth inducer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
- G01N2800/202—Dermatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Toxicology (AREA)
- General Physics & Mathematics (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1359246A FR3010904B1 (fr) | 2013-09-25 | 2013-09-25 | Bacteries du genre stenotrophomonas et/ou inducteur de croissance desdites bacteries pour la prevention et/ou le traitement de la dermatite atopique |
PCT/EP2014/070578 WO2015044318A2 (fr) | 2013-09-25 | 2014-09-25 | Bactéries du genre stenotrophomonas et/ou inducteur de croissance desdites bactéries pour la prévention et/ou le traitement de la dermatite atopique |
US15/024,620 US20160235791A1 (en) | 2013-09-25 | 2014-09-25 | Bacteria of the stenotrophomonas genus and/or growth inducer of said bacteria for preventing and/or treating atopic dermatitis |
EP14781109.5A EP3049093A2 (fr) | 2013-09-25 | 2014-09-25 | Bactéries du genre stenotrophomonas et/ou inducteur de croissance desdites bactéries pour la prévention et/ou le traitement de la dermatite atopique |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1359246A FR3010904B1 (fr) | 2013-09-25 | 2013-09-25 | Bacteries du genre stenotrophomonas et/ou inducteur de croissance desdites bacteries pour la prevention et/ou le traitement de la dermatite atopique |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3010904A1 FR3010904A1 (fr) | 2015-03-27 |
FR3010904B1 true FR3010904B1 (fr) | 2017-08-11 |
Family
ID=50478478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1359246A Active FR3010904B1 (fr) | 2013-09-25 | 2013-09-25 | Bacteries du genre stenotrophomonas et/ou inducteur de croissance desdites bacteries pour la prevention et/ou le traitement de la dermatite atopique |
Country Status (4)
Country | Link |
---|---|
US (1) | US20160235791A1 (fr) |
EP (1) | EP3049093A2 (fr) |
FR (1) | FR3010904B1 (fr) |
WO (1) | WO2015044318A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114032203B (zh) * | 2021-12-17 | 2023-11-21 | 海信冰箱有限公司 | 一株可抑制亚硝胺生成的嗜根寡养单胞菌及其应用 |
CN115287225B (zh) * | 2022-06-29 | 2023-06-02 | 昆明学院 | 一株寡养单胞菌菌株kc098,其发酵液及应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003057861A2 (fr) * | 2002-01-07 | 2003-07-17 | Manas Ranjan Banerjee | Rhizobacteries sulfo-oxydantes favorisant la croissance des plantes pour ameliorer le rendement du canola |
FR2954140A1 (fr) * | 2009-12-17 | 2011-06-24 | Oreal | Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques |
-
2013
- 2013-09-25 FR FR1359246A patent/FR3010904B1/fr active Active
-
2014
- 2014-09-25 EP EP14781109.5A patent/EP3049093A2/fr not_active Withdrawn
- 2014-09-25 WO PCT/EP2014/070578 patent/WO2015044318A2/fr active Application Filing
- 2014-09-25 US US15/024,620 patent/US20160235791A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20160235791A1 (en) | 2016-08-18 |
WO2015044318A3 (fr) | 2015-06-18 |
EP3049093A2 (fr) | 2016-08-03 |
FR3010904A1 (fr) | 2015-03-27 |
WO2015044318A2 (fr) | 2015-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279752B (en) | Polycyclic compounds and their use in the treatment of immune disorders | |
IL273688A (en) | Evaluation and treatment of bradykinin-mediated disorders | |
IL244682A0 (en) | Methods and systems for treatment by using intervention and providing tasks | |
EP3082431A4 (fr) | Compositions bactériennes et leurs méthodes d'utilisation pour traiter des troubles du système immunitaire | |
GB2554629B (en) | Prevention and treatment of microbial infections | |
FR3011009B1 (fr) | Signature bacterienne de la dermatite atopique et son utilisation dans la prevention et/ou le traitement de cette pathologie | |
MA41119A (fr) | Méthodes de traitement de syndromes myélodysplasiques et d'anémie sidéroblastique | |
FR3011467B1 (fr) | Composes et compositions comprenant de tels composes pour la prevention ou le traitement des dyslipidemies | |
MX2020002852A (es) | Tratamiento mejorado de dermatitis atopica con tradipitant. | |
EP2961420A4 (fr) | Méthodes et compositions de prévention ou de traitement du syndrome de barth | |
FR3010188B1 (fr) | Procede theragnostique pour le traitement des rhumatismes inflammatoires chroniques | |
FR2999191B1 (fr) | Souches probiotiques pour le traitement et/ou la prevention de la diarrhee | |
EP3019188A4 (fr) | Méthodes de traitement des troubles inflammatoires et de prophylaxie concernant des troubles inflammatoires | |
EP2955159A4 (fr) | Filtre de traitement de liquides à nanoparticules de magnétite et procédés correspondants | |
EP2964227A4 (fr) | Traitement et prophylaxie de maladies rénales | |
FR3010904B1 (fr) | Bacteries du genre stenotrophomonas et/ou inducteur de croissance desdites bacteries pour la prevention et/ou le traitement de la dermatite atopique | |
MA51647A (fr) | Compositions et méthodes pour le traitement de la dermatite atopique et la sélection du traitement | |
HK1257289A1 (zh) | 治療和/或預防特應性皮炎的il-17c拮抗劑 | |
HK1243961A1 (zh) | 炎性病况的預防和治療 | |
FR3002024B1 (fr) | Installation de production et de traitement de fumees | |
PL3021858T3 (pl) | Szczep cu1 do leczenia i/lub profilaktyki przewlekłych zapalnych chorób reumatycznych | |
FR3020471B1 (fr) | Procede de traitement de surface d'une piece transparente et piece ainsi traitee | |
EP3423049A4 (fr) | Méthodes de traitement ou de soulagement de troubles mentaux et des symptômes associés | |
FR3029114B1 (fr) | Composition nutritionnelle infantile dans le traitement de la dermatite atopique et de ses symptomes | |
AU2015905047A0 (en) | Methods of treating or alleviating mental disorders and associated symptoms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 9 |
|
PLFP | Fee payment |
Year of fee payment: 10 |
|
PLFP | Fee payment |
Year of fee payment: 11 |